Showing posts with label rheumatoid. Show all posts
Showing posts with label rheumatoid. Show all posts

Sunday 23 December 2018

Women Suffer From Rheumatoid Arthritis More Often Than Men

Women Suffer From Rheumatoid Arthritis More Often Than Men.
Rheumatoid arthritis patients can by and large looks forward to a much better quality of life today than they did 20 years ago, brand-new research suggests. The observation is based on a comparative multi-year tracking of more than 1100 rheumatoid arthritis patients. All had been diagnosed with the often fatally debilitating autoimmune disorder at some point between 1990 and 2011. The reason for the brighter outlook: a combination of better drugs, better annoy and mental health therapies, and a greater effort by clinicians to boost patient spirits while encouraging continued true activity.

And "Nowadays, besides research on new drug treatments, examination is mainly focused on examining which treatment works best for which patient, so therapy can become more 'tailor-made' and therefore be more effective for the mortal patient," said Cecile Overman, the study's lead author. Overman, a doctoral observer in clinical and health psychology at Utrecht University in the Netherlands, expects that in another 20 years, rheumatoid arthritis patients will have the same property of life as anyone else "if the focus on the whole patient - not just the disease, but also the person's abstract and physical well-being - is maintained and treatment opportunities continue to evolve. The con was released online Dec 3, 2013 in Arthritis Care and Research.

In rheumatoid arthritis, the body's inoculated system mistakenly attacks the joints, the Arthritis Foundation explains. The resulting infection can damage joints and organs such as the heart. Patients practice sudden flare-ups with warm, swollen joints, pain and fatigue. Currently there is no cure but a discrepancy of drugs can treat symptoms and prevent the condition from getting worse.

Up to 1 percent of the world's populace currently struggles with the condition, according to the World Health Organization. The current study was composed on the whole of female rheumatoid arthritis patients (68 percent). Women are more prone to developing the ready than men. Patients ranged in age from 17 to 86, and all were Dutch.

Each was monitored for the strike of disease-related physical and mental health disabilities for anywhere from three to five years following their opening diagnosis. Disease activity was also tracked to assess progression. The observed trend: a striking two-decade drop in physical disabilities. The researchers also saw a decline in the incidence of eagerness and depression.

Friday 17 March 2017

New Researches In Treatment Of Rheumatoid Arthritis

New Researches In Treatment Of Rheumatoid Arthritis.
About half of rheumatoid arthritis patients stopped taking their medications within two years after they started them, a reborn on finds June 2013. Rheumatoid arthritis affects about one in 100 commoners worldwide and can cause leftist joint destruction, deformity, pain and stiffness. The disease can reduce solid function, quality of life and life expectancy. The main reason about one-third of patients discontinued their medications was because the drugs accursed their effectiveness, the study authors found. Other reasons included safe keeping concerns (20 percent), doctor preference (nearly 28 percent), passive preference (about 18 percent) and access to treatment (9 percent), according to the swatting results, which were presented Thursday at the annual meeting of the European League Against Rheumatism (EULAR), in Madrid, Spain.

Rheumatoid arthritis "is a step by step disease, which, if left untreated, can significantly and always reduce joint function, patient mobility and quality of life," study lead designer Dr Vibeke Strand, a clinical professor at Stanford University School of Medicine, said in an EULAR copy release. "Studies have shown that patients sustain maximum benefit from rheumatoid arthritis healing in the first two years - yet our data highlight significant discontinuation rates during this duration period".